Cavan John T 4
4 · Hepion Pharmaceuticals, Inc. · Filed Aug 21, 2020
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Stock Options
2020-08-19+160,000→ 381,060 totalExercise: $3.72Exp: 2030-08-19→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]53,333 of the stock options vest on 8/19/2021 and the remainder vests monthly in equal amounts over 24 months.